TASE Screen: Liquid, Intraday-Volatile, Steadily-Rising, Sub-₪10 Stocks Trading Below Estimated Value

What it is

An evergreen, externally-managed Israeli infrastructure investment fund, listed on TASE since November 2021. It buys controlling / joint-control stakes in mature operating infrastructure companies across digital infrastructure (Excelera / ex-Tamares Telecom subsea fibre and data centres, Tiber cellular towers), energy (Esco Aluma energy-efficiency ESCO, and from July 2026 Alumenergi / Supergas Natural — industrial natural gas, cogeneration and CNG) and environmental services (Chen HaMakom, Greenmix construction-waste recycling). It reports on an investment-entity basis, carrying holdings at fair value, so "revenue" is mostly mark-to-market movement rather than operating sales.

Chain of reasoning (NAV / sum-of-the-parts)

1. Establish NAV. Stated NAV = shareholders' equity, since all holdings are carried at fair value: ₪468.084m at 31-Dec-2025 and ₪462.323m at 31-Mar-2026 on 307,392,380 shares = 150.4 agorot/share (FY25 basis: 468.084m / 307.39m × 100 = 152.3 ag). At 89.1 the stock trades at 0.59× NAV — a 41% discount.
2. Is the NAV credible? The Q1-2025 investor presentation gives asset-level marks (₪m, fund's share, at 31-Mar-25): Excelera 362.8 (81.6% stake, cost 173), Tiber 46.9 (91%, cost 46), Esco Aluma 95.5 (57.7%, cost 53), Chen HaMakom 37.3 (35%, cost 47.5 — i.e. marked down 16%) = 542.5 total investments, vs equity 439.6m and net financial debt ~57m. The fund does write assets down, which argues against systematic inflation.
3. Roll the balance sheet forward (₪m). Q1-26 cash 241.2, LT liabilities 343.8 (of which ~301 bonds). Then: +435 Excelera proceeds (received after balance-sheet date) = 676.2; −45 Greenmix investment (Apr-26) = 631.2; −129.75 early redemption of Series B bonds (21-Jun-26) = 501.5; −281 cash for 100% of Supergas Natural (8-Jul-26; total price ~406 = 281 cash + 11 net-debt adjustment + 114 deferred over 24 months) → ~220 cash. Fund-level net debt ≈ 171 (residual bonds) + 114 (deferred consideration) − 220 (cash) = ~₪65m. Implied enterprise value at market price = 273.9 + 65 = ~₪339m.
4. Cross-check on look-through EV/EBITDA. Portfolio EBITDA attributable to the fund was ~₪65m LTM at Q1-2025 (+64% y/y), of which Excelera (now sold) was roughly ₪23m. Rebuilding the post-transaction run-rate: Supergas Natural 100% × ₪39.1m 2025 EBITDA = 39; Esco (~36% residual of a company valued at 160m at ~8× ⇒ ~20m EBITDA) ≈ 7; Tiber (91%) ≈ 5; Chen HaMakom (35% of a business with ~₪170m EV) ≈ 7; Greenmix ≈ 4. Look-through EV/EBITDA ≈ 7.0× versus the 10.4× Aluma itself paid for Supergas and 8–11× for listed infrastructure peers; ~8.5× on EBITDA net of fund-level fees.
5. A structural discount is unavoidable. No wind-down date, no distribution policy, no dividend, so nothing forces the NAV discount to close — and it has not closed since the November 2021 listing (the share price is still below its issue level while NAV per share has risen). Management fees plus carry are a permanent ~1.5–2%/yr leak from NAV; capitalised, that drag alone justifies a 15–25% discount before any other risk.

Where the skeptic cut it (105 → 92)

The analyst's central claim — that two arm's-length exits cleared above book, proving the Level-3 marks conservative — is factually wrong:

• False "exit above book" — the load-bearing error. The analyst compared the Dec-2025 Excelera realisation (₪435m to Aluma) against a stale Mar-2025 mark of ₪362.8m. Calcalist reports Aluma's books showed Excelera at a net asset value of ₪449m as of Q3-2025. The skeptic triangulated this independently against the Dec-25 balance sheet: total assets 642.157m less cash 8.260m = 633.9m of investments; Excelera 449 + Tiber 46.9 + Esco 95.5 + Chen HaMakom 37.3 = 628.7m (near-perfect fit), whereas the analyst's 362.8m assumption gives only 542.5m and leaves ~91m unexplained. So Excelera was sold ~3% BELOW carrying value, not above it — and the ₪480m Bezeq offer that would have been above book collapsed.
• Same error repeated on Esco, sourced from a promotional outlet. The Q1-25 presentation carries Esco at ₪95.5m for a 57.7% stake, implying ₪165.5m for 100%. The Discount Capital / Bar Mashiah deal was struck at a ~₪160m company valuation — roughly 3% below the implied mark. The "well above book" language traces to sponser.co.il, a paid-promotion financial site carrying company-sourced wording. The presentation's "+95%" is a return on cost (₪53m), not versus book.
• Circular NAV logic / double-counted validation. FocusFin's FY2025 note confirms the ~₪27m profit "arose almost entirely from unrealised fair-value increases" — i.e. Aluma marked Excelera up from 362.8m toward the pending deal price during H2-2025 (Q3 income +40.7m, Q4 +31.6m). The deal price is therefore already embedded in the ₪462–468m NAV the analyst anchors on; citing the same transaction again as independent evidence of conservatism counts it twice.
• NAV anchor ~₪12–14m too high. Realising Excelera at 435 against a ~449 carrying value implies a ~₪14m NAV hit landing in Q2-2026 (not yet reported). Adjusted NAV ≈ ₪448m = 145.8 agorot/share, not the ~460m / 149.6 ag used.
• Fund-level net debt understated by ~₪25–43m. Q1-26 reports non-current liabilities of 343.777m plus current liabilities of 10.731m, but the Step-3 bridge silently carries only "~301m bonds" and drops the remainder (likely deferred tax on unrealised gains, which is real and crystallises on realisation). Corrected fund-level net debt ≈ ₪95m, not ~₪65m — which moves the headline look-through EV/EBITDA from 7.0× to ~7.7×.

Applying a defensible ~37% structural discount to the corrected NAV gives 92.

Bull points (analyst)

• Trades at 0.59× stated NAV (89.1 vs 150.4 ag/share).
• Realised money-on-invested-capital of ~3.5× on Excelera and ~4× on Esco; the fund has demonstrated it can actually monetise assets, not just mark them up.
• The July-2026 Supergas Natural acquisition (₪39.1m EBITDA, ~50 connected industrial sites, 33MW of cogeneration plus 30MW in development, ~1,100 CNG buses) converts a semi-blind-pool fund into an owner of genuinely recurring, contracted industrial-energy cash flow — the single biggest historical criticism of the vehicle.
• Look-through EV/EBITDA of ~7.0× versus the 10.4× Aluma itself paid for Supergas and 8–11× for listed infrastructure peers.

Bear points (analyst)

• Structurally evergreen and externally managed: no wind-down date, no distribution policy and no dividend, so there is no mechanism that forces the NAV discount to close — and it has not closed since listing.
• Management fees plus carry are a permanent ~1.5–2%/yr leak from NAV.
• NAV compounding has been mediocre: fund equity went ₪399m (Mar-23) → 441m (Mar-24) → 440m (Mar-25) → 468m (Dec-25) → 462m (Mar-26), roughly 5%/yr, thin for a leveraged infrastructure vehicle.
• Extreme concentration risk after redeploying essentially all realisation proceeds into a single asset: Supergas Natural at ~₪406m (10.4× 2025 EBITDA) is now the majority of NAV, was bought at a full price, and reportedly lacked complete standalone 2024–2025 financials.

Key financials

FY2025 (fund level, IFRS investment-entity basis): total income ₪60.3m; net income ₪26.8m (almost entirely unrealised fair-value uplift; operating cash flow about −₪12m); shareholders' equity / NAV ₪468.1m. Q1 2026 (31-Mar-26): total income −₪9.4m; operating −₪13.2m; net loss −₪10.4m (non-cash FX-driven portfolio mark-down); total assets ₪816.8m; equity ₪462.3m (= 150.4 ag/share); cash ₪241.2m; non-current liabilities ₪343.8m (~₪301m bonds). Estimated fund-level net debt after the June-26 ₪129.75m Series B redemption and the July-26 Supergas purchase: ~₪65m (skeptic: ~₪95m). Look-through portfolio EBITDA attributable to the fund: ~₪65m LTM at Q1-2025; ~₪62–65m post-transaction run-rate.

Why it still passes

Even on the skeptic's corrected NAV and a wide discount, 92 > 89.1. The discount is the entire thesis — there is no catalyst that forces it to close.

What it is

A Panama-incorporated, TASE-listed pure holding company whose only material asset is a controlling stake in G City Ltd. (formerly Gazit Globe), the global supermarket-anchored shopping-centre owner (Israel; Poland/CEE via Atrium; Nordics via Citycon 86.6%; plus US/Brazil legacy). Norstar itself has no operations — it services solo holdco debt out of dividends received from G City. On 3 July 2026 it agreed to sell 44.2m G City shares (26% of issued capital) to Tzahi Abu's Ari Real Estate (ARIN) + Yishpro-Tenuport for ₪660.8m, handing over control and turning Norstar into a minority holder.

Chain of reasoning (look-through NAV)

Norstar fully consolidates G City, so the fact-sheet figures "revenue ₪2.55bn / EBITDA ₪1.43bn / debt ₪22.7bn" are G City's numbers and are meaningless at the Norstar level — they were discarded. A holdco whose sole asset is a listed stake must be valued on look-through NAV, not consolidated earnings.

1. The asset. G City (TASE: GCT) closed 28/07/2026 at 1,247 ag = ₪12.47, issued capital 170,833,487 shares, market cap ₪2,130m. Norstar's immediate report of 3/7/2026 states it holds ~54.48% via Norstar Israel Ltd ⇒ 0.5448 × 170.83m = 93.07m G City shares.
   Cross-checks (all four reconcile): (a) the sale is 44.2m shares = 25.9% of 170.83m ("26% of issued capital"); (b) Norstar retains 93.07 − 44.2 = 48.87m = 28.6% — Ynet reports "retains 28%"; (c) the 7% option block (12m shares) takes the buyer to (44.2+12)/170.83 = 32.9% ("option to reach ~33%") and Norstar to 36.87m = 21.6% ("Norstar drops to 21%").
   Reconciliation with the Oct-2025 Midroog report (49.7% stake): G City executed a ~₪100m buyback in Feb-2026 at ~₪7/share (~14m shares) and cancelled them, mechanically lifting Norstar from ~49.7% of ~185m shares to ~54.5% of 170.8m. Norstar's absolute share count barely moved.
2. Contracted sale. 44,200,000 × ₪14.95 = ₪660.8m. Terms: ₪230m at closing, ₪430.8m deferred ≤6 months, ₪20m deposit posted, 90-day long-stop (~1 Oct 2026), conditional on Israeli antitrust approval. Haircut 5% for completion + deferred-payment credit risk ⇒ ₪627.8m.
3. Retained block. 48.87m shares × ₪12.47 (market) = ₪609.4m. No blockage discount applied (a 28.6% stake with a voting agreement retains strategic value); equally no control premium.
4. Option package. Norstar holds a put on 12m shares at ₪16; the buyer holds a call on 12m at ₪17. Intrinsic value of the put floor = 12m × (16.00 − 12.47) = ₪42.4m, credited at 60% for timing/counterparty risk ⇒ ₪25.4m.
5. Equity-raise commitment. ₪260m to be injected into G City's planned ₪1bn equity raise — treated as value-neutral (cash converted into shares at roughly market). It does mean only ~₪401m of the ₪661m actually goes to deleveraging.
6. Solo net debt. Midroog (27/10/2025) reports Norstar solo-extended net financial debt of ₪572m at 30/06/2025 (₪564m at 31/12/2024, ₪566m at 31/12/2023), cash ₪27m plus ₪159m undrawn committed lines, ₪72m raised via a Series 14 tap in Sep-2025, 2026 bond amortisation ₪117m.
7. NAV before discount ≈ ₪702.6m; apply a holding-company discount, then divide by 62,352,413 shares. At a 10% discount: 702.6 × 0.90 / 62,352,413 × 100 = 1,014.1 agorot.

Where the skeptic cut it (1015 → 865)

The skeptic explicitly could not break the factual base — no unit error, no sourcing error. They reproduced the arithmetic exactly, independently confirmed prices and share counts on Bizportal (NSTR 853.1 ag, 62,352,413 shares, mcap ₪531.9m, equity ₪1,724m; G City 1,247 ag, 170,833,487 shares), confirmed the deal terms from two independent sources, and extracted the Midroog 27/10/2025 PDF with pdftotext, finding every solo figure quoted verbatim correct. The problem is the judgement layer, and it is biased one way:

• Asymmetric completion-risk treatment. The sold 44.2m block gets a 5% deal-risk haircut, but the retained 48.87m block is marked at ₪12.47 with zero adjustment — and 12.47 is itself a deal-inflated price (G City rose ~10% from 1,133 on 2/7/2026 to 1,247 on the announcement). If antitrust blocks the deal, both marks fall. Probability-weighting both at p(close)=0.82 with a break-price of ₪11.30 costs ~₪10m on the retained block, and reveals that the 5% haircut implies an ~81% completion probability that is never stated.
• The 10% holding-company discount contradicts the analyst's own bear case, which states that such stubs "trade at 15–30% discounts to NAV indefinitely unless management liquidates — and there is no announced plan to do so." Using the midpoint of his own stated range (22.5%) takes fair value to ~845 ag, i.e. the entire 19% upside disappears on an input he himself argued against. This is the single largest lever in the model and it is cherry-picked.
• The model ignores that Norstar is a levered stub, and that deleveraging destroys option value. Using the confirmed G City YTD of +63.92% and NSTR YTD of +31.79%: at 1/1/2026 G City was 760.7 ag, so Norstar's intrinsic NAV was 708 − 563 = ₪145m = 233 agorot while the stock traded at 647 — a 178% PREMIUM to NAV. Today NAV is 963 and the stock is 853 — an 11.4% DISCOUNT. The "discount to NAV" this whole valuation rests on has swung from +178% to −11% in seven months because the equity is a call option on G City. Post-deal, leverage falls from 48% to ~18%, removing exactly the optionality that has been holding the price above intrinsic NAV. The analyst books deleveraging as unambiguously good; for the equity holder (as opposed to the bondholder) it is partly value-destroying.
• Overstated claim. "The market is giving essentially zero credit for the ₪110m premium" is not established — G City itself re-rated ~10% on the announcement, adding ~₪106m to Norstar's look-through NAV, and that gain is already embedded in the 12.47 mark used for the retained block. NSTR is also +6.33% month-to-date since the 3/7 announcement. The market has given partial credit; the residual gap is a probability discount on a binary antitrust decision, not an oversight.

Bull points (analyst)

• A signed, priced contract sets a hard mark on 47% of the asset: 44.2m G City shares at ₪14.95 vs ₪12.47 market — ₪110m (21% of Norstar's entire market cap) of value the market is not paying for.
• Deleveraging is transformational at the holdco: ₪661m of proceeds against ~₪560m of solo net debt; even after the ₪260m equity-raise commitment, net debt falls to roughly ₪160m, ending the refinancing treadmill that has capped the rating at Baa2.il and driven the discount for four years.
• Free put option: Norstar can sell a further 12m shares to the buyer at ₪16 (28% above spot), with the buyer's call at ₪17 — ₪42m of intrinsic value at no cost.
• Katzman is effectively out (down to ~9.3% of Norstar from ~32% in Oct-2025), with Israel-Canada 14.6% and Aurora 13.2% now the largest holders — a shareholder base that wants the pyramid flattened. An in-kind distribution or liquidation would collapse the holdco discount entirely.

Bear points (analyst)

• Execution risk is binary and near-term: the deal needs Israeli antitrust clearance within 90 days, and only ₪230m is paid at closing — ₪430.8m is deferred up to six months against a ₪20m deposit, leaving Norstar with unsecured credit exposure to a leveraged buyer (Ari Real Estate itself has ₪1.69bn of debt against ₪1.6bn of market cap).
• If the deal breaks, G City almost certainly retraces the 32% control premium and Norstar's NAV falls to roughly 580 agorot — a ~32% downside, i.e. the risk/reward is close to symmetric, not a one-way bet.
• Double leverage: ₪560m of solo debt sits behind a stake in a company that is itself ~66% LTV. A 20% fall in G City's share price wipes out ~44% of Norstar's NAV.
• ₪260m of the ₪661m proceeds is contractually recycled straight back into G City's ₪1bn equity raise, so Norstar does not end up debt-free — and it will be subscribing to a company trading at half book, dilutive to G City's book value per share.

Key financials

Norstar solo (the only figures that matter): net financial debt ₪572m at 30/06/2025 (₪564m at 31/12/2024) per Midroog Oct-2025; cash ₪27m + ₪159m undrawn lines at 30/06/2025; 2026 bond maturities ₪117m, 2027 ₪194m; HQ + finance costs ~₪35m/yr; dividends received from G City ~₪48m/yr; leverage (net debt / market value of G City stake) 48% at 30/06/2025; rating Baa2.il stable. Sole asset: 93.07m G City shares (54.48%), carried at ~₪1,910m in the books at 30/06/2025 vs ~₪1,161m market value today.
Norstar consolidated (= G City consolidated, low information value): Q1 2026 revenue ₪556–559m; net income −₪4m; total assets ₪32.6bn; gross debt ₪22.5bn.

Bottom line

The cleanest balance-sheet arithmetic of the four, but the upside is a binary antitrust decision, and downside if the deal breaks is ~−32%.

What it is

A small Israeli telecom-services group operating three segments: (1) defence & government satellite/communications — 63% of FY2025 revenue, mostly Israeli MoD / security customers, the current growth engine; (2) a global business segment selling satellite and fibre connectivity to carriers, ISPs and enterprises in Africa and the Middle East — 26% of revenue and structurally shrinking; (3) an Israeli ISP / cloud / integration business — 11% of revenue, ~23k residential and ~350 business customers, built on a long-term IRU fibre agreement with Bezeq. It leases satellite capacity and fibre rather than owning it, so the model is asset-light on capex but lease-heavy on opex.

Chain of reasoning (EV / Adjusted EBITDA on a fully diluted base)

1. The critical adjustment is the share count. The headline 118,813,554 shares and ₪270m market cap are correct for shares issued today, but ignore two deep-in-the-money convertible series that will convert:
   • Series D (TASE 1218205, issued Feb-2025, ₪45,872,000 par; ₪41,603,076 par still outstanding at the 26-Mar-2026 annual report). Conversion ₪1.00 par → 1 share until 1.4.2028. It now trades at 227.8 ag with a series market value of ~₪66.4m ⇒ outstanding par = 66.4/2.278 = ~₪29.2m ⇒ ~29.2m new shares.
   • Series C (TASE 1177823, ₪1.35 par → 1 share, conversion window ends 22-Aug-2026, final principal 1-Sep-2026). Trades at 172.5 ag, series market value ~₪13.1m ⇒ par = 13.1/1.725 = ~₪7.6m ⇒ 7.6/1.35 = ~5.6m new shares.
   • Cross-check: shares went from 93,937,313 (31-Dec-2025, audited note 16) to 118,466,054 today = 24.5m issued in 2026 YTD, of which ~12.4m par from Series D. The residual 12.1m implies ~16.3m par of Series C converted — consistent with the ~₪7.6m par still outstanding.
   • Add ~4m net shares from the 5.5m + 4.0m employee option packages (net-exercise, strikes at 1% and 20% premiums to grant-date VWAPs).
   ⇒ Fully diluted ≈ 157m; 155m used centrally. Management's own FY2025 diluted weighted-average was 150,272k vs 89,777k basic — independent confirmation. ⇒ True diluted market cap = 155m × 227.3 ag = ₪352m, not ₪270m. The stock is ~30% more expensive than screens show.
2. Normalised EBITDA. The company reports "Adjusted EBITDA", stripping out the IFRS-16 effect of capitalising satellite-capacity leases — i.e. treating leased capacity as an operating cost. That is economically correct here, so it is used, and lease liabilities are correspondingly excluded from net debt. Audited FY2025 quarterly Adjusted EBITDA (USD 000): Q1 2,719 / Q2 3,250 / Q3 3,824 / Q4 4,993 = 14,786 (vs 8,728 in FY2024, +70%). Translated at the quarterly USD/ILS rates the company itself used (Q1-25 = 3.60; ~3.38 Q3; ~3.27 Q4): FY2025 Adjusted EBITDA ≈ ₪51m. Q1 2026 actual (now reported in ₪): revenue ₪68.5m, Adjusted EBITDA ₪14.2m, net profit ₪7.35m.
   Honest caveat carried by the analyst: Q1-26 is +45% YoY but down sequentially — Q4-25 was $4,993k × 3.27 = ~₪16.3m adj. EBITDA and $3,160k × 3.27 = ~₪10.3m net profit. The "+93%" headline is against a weak Q1-25 comp.
3. Balance sheet. Net-cash: ~₪50m net financial asset, ₪90.5m of cash and deposits; net debt/EBITDA 0.11× against a 5× covenant limit.
4. Apply an EV/Adjusted-EBITDA multiple to FY2026E run-rate on the 155m diluted base, cross-checked with a DCF and a forward P/E. ₪435m / 155m = ₪2.81 = 281 agorot (analyst's central 285).

Where the skeptic cut it (285 → 212)

The skeptic confirmed there are no unit errors and independently verified the headline financials — Q1-2026 revenue ₪68.5m (+18.5%), gross profit ₪21.2m, Adjusted EBITDA ₪14.2m (+45% vs ₪9.8m), net profit ₪7.35m (+93% vs ₪3.85m), equity ₪119.0m (from ₪77.6m), cash and deposits ₪90.5m, net financial asset ~₪50m, backlog ₪182.2m — all confirmed via PR Newswire and Bizportal. They also independently reproduced the dilution work from live market data and called it "the best part of the analysis." The cuts are:

• Material omission — the Bezeq fibre IRU is a cost Gilat PAYS, not a free option. Verified: ~₪600m over 15 years, of which Phase 1 (36,000 lines, ~₪160m) is already committed and being paid over three years starting Dec-2025 (~₪400m of the total is one-time upfront payments; later phases optional). That is ~₪53m/yr of committed cash outflow, against a company with ₪90.5m of total cash and a ₪355m diluted market cap. The analyst cites this deal only as a bull point ("access to up to 90,000 fibre lines") and it appears nowhere in net debt, capex or FCFF.
• Directly contradicted capex assumption. The DCF uses capex of ~₪8m/yr, justified as "FY2025 real capex was only $1.45m; asset-light." That is untenable against the committed ~₪53m/yr Bezeq IRU spend. Consequently the claim of "surplus net cash = ₪75m" is not defensible — the cash pile is largely earmarked. Both the multiple bridge and the DCF are inflated by the same omission.
• Cash conversion overstated, and the company's own disclosure shows it. FY2025 FCF was $7.83m against Adjusted EBITDA of $14.79m = 53% conversion (the gap is explicitly "prepaid expenses", ~$2.9m, consistent with IRU prepayments already starting). The DCF assumes ₪39m of FCFF on ₪60m of Adjusted EBITDA = 65% conversion. The analyst quotes the $7.83m figure and then models above it.
• FY2026E Adjusted EBITDA of ₪60m contradicts the analyst's own bear case. Q1-26 (₪14.2m) was down 13% sequentially from Q4-25 (₪16.3m), yet Q2/Q3/Q4 are modelled at 15/16/16. The analyst himself states that (i) a single ₪52m ten-month contract worth ~23% of quarterly revenue expires around October 2026 with no renewal visibility, and (ii) a strong shekel is a persistent headwind on ~⅓ USD-denominated revenue. Neither is reflected. TTM is ₪55m and Q1 annualises to ₪57m.
• Multiple cherry-picked at the top of the analyst's own comp range. He cites Israeli telcos at 4.5–6.0× and then selects 6.0× — the very top — for a company that is far more concentrated (63% single-country defence), far less liquid (~550 trades/day), more disruption-exposed (LEO), and with a history of losses and near-distress. The entire 25% upside IS the multiple: on his own FY2026E figures the market currently pays ~4.4–4.8×.

Bull points (analyst)

• Genuine, audited operating turnaround: Adjusted EBITDA +70% in FY2025 and +45% YoY in Q1 2026, gross margin up from 23.2% to 31%, with four sequentially improving quarters through 2025.
• Net cash balance sheet (~₪50m net financial asset, ₪90.5m of cash and deposits) with covenants met by an enormous margin — net debt/EBITDA 0.11× against a 5× limit.
• The growth engine is Israeli defence/government satellite communications, 63% of revenue, supported by elevated Israeli security spending; segment revenue rose 30% to $48.1m in FY2025 and segment profit reached ₪20.2m in Q1 2026 on ₪58.7m of revenue.
• Asset-light economics: FY2025 capex was only $1.45m against $14.8m of Adjusted EBITDA, so incremental growth needs almost no capital and converts to cash (FY2025 operating cash flow $20.5m).

Bear points (analyst)

• Roughly 30% dilution is still to come — on ~155m fully diluted shares the market cap is ₪352m, not ₪270m. Any screen using the headline share count materially overstates how cheap this is.
• Q1 2026 was weaker sequentially, not stronger: Q4 2025 Adjusted EBITDA ~₪16.3m and net profit ~₪10.3m, versus ₪14.2m and ₪7.35m in Q1 2026. The "+93%" headline flatters a soft Q1 2025 comp.
• Revenue quality is poor. A single ₪52m order announced in January 2026 — a ten-month contract from an undisclosed Israeli customer — is worth roughly 23% of a quarter's revenue and expires around October 2026 with no renewal visibility. The ₪182.2m backlog stretches to 2029 and covers only ~0.67× of one year's revenue.
• Structural threat from LEO constellations (Starlink and peers) to a business that resells leased GEO satellite capacity. The Africa/global segment is already shrinking: $24.7m (2023) → $19.2m (2024) → $18.8m (2025).

Key financials

FY2025 (audited, reported in USD): revenue $75.79m (+8.9% vs $69.59m); gross profit $23.05m, 30.4% margin (vs 23.2%); operating profit $9.69m (vs $4.95m); EBITDA $23.87m; Adjusted EBITDA (post satellite-lease) $14.79m (vs $8.73m, +70%); GAAP net profit $6.35m, non-GAAP $8.04m; operating cash flow $20.53m; free cash flow $7.83m; capex only $1.45m. Revenue by geography: Israel $56.45m, Africa $18.76m (down from $24.66m in 2023), other $0.58m. Segment mix: defence/government 63%, global business 26%, Israeli ISP 11%.
Q1 2026 (reported in ₪ after the functional-currency change): revenue ₪68.5m (+18.5% YoY); gross profit ₪21.2m, 31.0% margin; EBITDA ₪21.4m; Adjusted EBITDA ₪14.2m (+45%); net profit ₪7.35m (+93%); equity ₪119.0m; cash and deposits ₪90.5m; backlog ₪182.2m.

Bottom line

The best technical fit of the four and the only one that essentially meets the liquidity bar — but the fundamental case is the weakest, and note the MA10 has been falling for the past month (−0.41%/day) after a +62% six-month run.

What it is

A pure holding company with essentially one asset: a 24.52% controlling stake in Bazan / Oil Refineries Ltd. (TASE: ORL), Israel's largest refining and petrochemical group in Haifa Bay. PTCH itself has zero revenue, ~₪4m/yr of holdco overhead, and carries roughly ₪535–565m of bonds issued in 2022 to buy Israel Corp's block of Bazan. It does not consolidate Bazan; the stake is carried by the equity method.

Chain of reasoning (look-through NAV)

1. Why NAV. PTCH has no operations, no revenue (FY2025 revenue = 0), and a single listed asset. NAV/SOTP is the only method that fits — earnings multiples are meaningless (FY2025 net loss ₪81.7m, no trailing P/E).
2. Size the stake. 24.52% of ORL × 3,121,087,420 ORL shares = 765.3m ORL shares.
3. Verify the stake independently — the load-bearing check. Investing.com's PTCH balance sheet at 31/12/2025 shows "long-term investments" = ₪1,376.0m, total assets ₪1,422.1m (i.e. the Bazan stake IS essentially the whole balance sheet). Bazan FY2025 shareholders' equity = $1.75bn. Equity-method carrying value should = 24.52% × $1.75bn × FX. At USD/ILS 3.20: 1,750 × 3.20 × 0.2452 = ₪1,373m vs ₪1,376m reported — a match within 0.2%.
   This simultaneously confirms (a) the 24.52% stake is still current, (b) PTCH uses the equity method with no residual goodwill, and (c) Bazan's real book equity is ~₪5.6bn (~179 ag/share), NOT the 64.5 ag/share in the Yahoo fact-sheet line — so ORL trades at ~1.05× book, not 2.91×. The fact sheet's ORL P/B is unit-confused and was discarded.
4. Market value of the stake (gross asset value). 765.3m ORL shares × 188 ag = ₪1,438.7m. Cross-check: ORL market cap 3,121.09m × 1.88 = ₪5,867.6m; × 24.52% = ₪1,438.7m. ✓
5. Holdco net debt. Total debt ₪565.0m (Yahoo, most recent — reflects CPI linkage/accrued interest; investing.com shows ₪535.5m at 31/12/2025). Cash ₪5.5m. Other non-debt liabilities are trivial (total liabilities 551.2m vs debt 535.5m at YE25 ⇒ only ~15.7m other; no material deferred-tax liability). Net debt = 565.0 − 5.5 = ₪559.5m (the higher, more conservative debt figure is used).
6. NAV. 1,438.7 − 559.5 = ₪879.3m. Shares outstanding 102,154,268 ⇒ NAV/share = 879.3m / 102.154m = ₪8.607 = 860.7 agorot. At 532.5 the stock trades at 0.62× NAV — a 38.1% discount. Equivalently, EV = 544 + 559.5 = ₪1,104m vs gross asset value 1,439m, i.e. 77 agorot on the shekel of Bazan.
7. What discount is justified?
   Widening factors: Bazan pays no dividend, so PTCH has ₪6m of cash against ~₪565m of bonds and must refinance or sell shares; double leverage (Bazan itself carries ~$2bn net debt); the government's Haifa Bay evacuation decision (target 2029–2030) is a terminal-value overhang; repeated missile damage to the Haifa site (Jun-2025, and again Mar-2026); post-insolvency governance with a fragmented control group whose leading figure David Ferdman died in Feb-2026; the stock is thin (~140 deals/day) and has already run +180% in six months.
   Narrowing factors: LTV has fallen from ~68% to 39% as ORL rallied; Bazan is profitable again and government/insurance compensation is flowing (₪160m advance); large carried-forward tax losses mean a share sale is largely tax-sheltered; a 24.5% control block of strategic infrastructure historically sells at a premium (Israel Corp's 16.4% went for ₪550m in Sep-2022, ~107 ag/share vs a ~95 ag market price, i.e. a ~10–15% premium).
   Israeli single-asset holdcos routinely sit at 20–40% NAV discounts (Norstar, in this same screen, trades at 0.31× book). PTCH's own realised discount has been ~31–38% over the past six months. 30% is taken as the justified central discount — a mild compression, not a heroic one.
8. Fair value. Central: 860.7 × (1 − 0.30) = 602.5 ⇒ 600 agorot (upside +12.7% before the skeptic's cut).
   High 730: ORL held at spot, discount narrows to 15% on dividend resumption / Haifa Bay compensation clarity: 860.7 × 0.85 = 732.
   Low 465: ORL mean-reverts 10% to 169 ag ⇒ stake 765.3m × 1.692 = ₪1,294.9m; NAV = 1,294.9 − 559.5 = ₪735.4m ⇒ 720 ag/share; discount widens to 35% ⇒ 720 × 0.65 = 468.

Where the skeptic cut it (600 → 500)

Primarily by widening the discount back out — there is no catalyst for compression while Bazan pays no dividend, PTCH holds ₪6m cash against ₪565m of bonds, and the Haifa Bay evacuation decision (target 2029–30) is an unquantified terminal-value overhang on the sole asset, with recurring war damage to the site (Jun-2025, Mar-2026).

Bull points (analyst)

• Trades at a 38% discount to a look-through NAV of ~861 ag/share, backed by a fully liquid listed asset (765m ORL shares worth ₪1,439m) rather than illiquid private holdings.
• Balance-sheet triangulation is unusually clean: 24.52% × Bazan's $1.75bn equity × FX = ₪1,373m vs the ₪1,376m carrying value actually reported — the stake and the accounting both check out.
• Deleveraging by asset appreciation: holdco LTV has fallen from roughly 68% to 39% as ORL rallied 74% in six months, materially reducing refinancing risk.
• Bazan is back to profit (FY2025 operating profit $146m, net income $47m) and is receiving war-damage compensation, including a ₪160m government advance; a resumption of Bazan dividends would transform PTCH's debt-service story.
• The 24.5% block is a control position in strategic national infrastructure — Israel Corp sold 16.4% at roughly a 10–15% premium to market in 2022.
• Large accumulated tax losses mean gains on a sale of Bazan shares would be substantially tax-sheltered; there is no material deferred-tax liability on the balance sheet.

Bear points (analyst)

• Double leverage with no cash flow: PTCH holds ₪6m of cash against ~₪565m of bonds, and Bazan currently pays no dividend — debt service depends on refinancing or selling Bazan shares.
• The Haifa Bay evacuation decision (target ~2029–2030) is an unquantified terminal-value overhang on the sole asset; the compensation package is undefined.
• War risk is live and recurring, not historical: Bazan's Haifa site was damaged in Jun-2025 and again in Mar-2026.
• Thin trading (~140 deals/day) after a +180% six-month run.

Key financials

PTCH standalone FY2025 (31/12/2025): revenue ₪0 (pure holdco); operating loss ₪4.4m; net loss ₪81.7m; total assets ₪1,422.1m of which long-term investment in Bazan ₪1,376.0m; total liabilities ₪551.2m; total debt ₪535.5m (Yahoo latest ₪565.0m); cash ₪6.3m; shareholders' equity ₪870.9m (~852 ag/share; fact sheet BVPS 823.3 ag, likely Q1-2026). FY2024 comparatives: assets ₪1,598.6m, equity ₪1,089.6m, debt ₪491.1m.
Look-through asset — Bazan/ORL FY2025: revenue $5.84bn, operating profit $146m, net income $47m, shareholders' equity $1.75bn, total assets $4.45bn (Bazan reports in USD).
Market data 28-Jul-2026: PTCH 532.5 ag, mcap ₪544m, 102.15m shares, 52-week range 154.3–551.9; ORL 188 ag, mcap ₪5,868m.

Bottom line

Essentially a ~1.6× levered proxy on Bazan — and the ORL valuation in this same screen says Bazan is ~18% overvalued, so the two findings pull against each other. After a +180% six-month run this is the weakest of the four, and at 95–141 deals/day it badly misses the liquidity bar. Included only to reach four names.